Skip to content


Hereditary Cancer in Clinical Practice

Open Access

Risk-reducing surgery for breast and ovarian cancer risks - where are we now?

  • N Hallowell1,
  • B Baylock2,
  • L Heiniger2,
  • M Price2 and
  • P Butow2
Hereditary Cancer in Clinical Practice201210(Suppl 2):A13

Published: 12 April 2012


Ovarian CancerCancer ResearchCancer RiskNegative EmotionCosmetic Outcome

This talk will revisit some familiar issues about risk-reducing breast and ovarian surgery to manage cancer risks. I will focus upon the impact that surgery has on women’s lives and discuss their information needs. My talk will be illustrated with data collected during interviews with 40 Australian women as part of the kConFab Psychosocial study (Butow et al). Two emergent themes – looking different and feeling different - captured the psychosocial impact of surgery upon the interviewees. Many of the women said they felt differently about their bodies following RR surgery. All were relieved at having removed the risk of cancer that had previously been embodied in their breasts and ovaries, however reducing, risk by removing breasts and ovaries is not without costs. Interviewees reported experiencing a range of negative emotions and a series of unexpected bodily sensations following surgery and reflected upon positive and negative changes in their appearance. I will conclude that while women who undergo RR surgery are now informed about some of the sequelae, they are still not adequately prepared for the reality of undergoing this procedure. It will be suggested that, in addition to cosmetic outcomes, pre-surgical counselling needs to focus upon the experiential or sensational aspects of risk reducing surgery.

Authors’ Affiliations

Institute of Health & Society Newcastle University, UK
kConFab Psychosocial Group on behalf of the kConFab Investigators - Centre for Medical Psychology and Evidence-based Decision-making (CeMPED), University of Sydney, Australia


© Hallowell et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.